Addus Homecare Co. (ADUS) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Addus Homecare Co. (NASDAQ:ADUS) have been assigned an average recommendation of “Buy” from the six analysts that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $51.00.

Several equities analysts recently issued reports on the company. BidaskClub raised Addus Homecare from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 30th. Stephens set a $56.00 target price on Addus Homecare and gave the stock a “buy” rating in a research note on Monday, April 2nd. Robert W. Baird set a $43.00 target price on Addus Homecare and gave the stock a “hold” rating in a research note on Wednesday, March 14th. ValuEngine raised Addus Homecare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Finally, Zacks Investment Research lowered Addus Homecare from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 13th.

Shares of Addus Homecare stock opened at $53.45 on Tuesday. Addus Homecare has a 52 week low of $30.95 and a 52 week high of $55.75. The firm has a market capitalization of $618.53 million, a PE ratio of 36.86, a price-to-earnings-growth ratio of 1.77 and a beta of -0.40. The company has a current ratio of 3.01, a quick ratio of 3.01 and a debt-to-equity ratio of 0.22.



Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, March 5th. The company reported $0.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.03. Addus Homecare had a return on equity of 10.04% and a net margin of 3.28%. The business had revenue of $111.96 million for the quarter, compared to analyst estimates of $110.82 million. equities analysts forecast that Addus Homecare will post 1.99 earnings per share for the current fiscal year.

In other Addus Homecare news, CFO Brian Poff sold 613 shares of the stock in a transaction dated Thursday, May 10th. The stock was sold at an average price of $52.95, for a total value of $32,458.35. Following the sale, the chief financial officer now owns 22,770 shares of the company’s stock, valued at approximately $1,205,671.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider James Zoccoli sold 725 shares of the stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $35.90, for a total value of $26,027.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,151 shares of company stock worth $230,678. 35.80% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. OppenheimerFunds Inc. raised its position in Addus Homecare by 0.6% in the 1st quarter. OppenheimerFunds Inc. now owns 218,284 shares of the company’s stock valued at $10,619,000 after purchasing an additional 1,300 shares in the last quarter. Renaissance Technologies LLC raised its position in Addus Homecare by 2.4% in the 4th quarter. Renaissance Technologies LLC now owns 72,800 shares of the company’s stock valued at $2,533,000 after purchasing an additional 1,700 shares in the last quarter. Campbell & CO Investment Adviser LLC raised its position in Addus Homecare by 33.1% in the 1st quarter. Campbell & CO Investment Adviser LLC now owns 12,273 shares of the company’s stock valued at $597,000 after purchasing an additional 3,051 shares in the last quarter. Victory Capital Management Inc. raised its position in Addus Homecare by 6.7% in the 4th quarter. Victory Capital Management Inc. now owns 56,355 shares of the company’s stock valued at $1,961,000 after purchasing an additional 3,559 shares in the last quarter. Finally, MetLife Investment Advisors LLC acquired a new stake in Addus Homecare in the 4th quarter valued at about $146,000. 89.74% of the stock is currently owned by institutional investors.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply